Submitted for Publication: September 6, 2013; final revision received March 5, 2014; accepted April 1, 2014.
Published Online: August 21, 2014. doi:10.1001/jamaoto.2014.1800.
Study concept and design: Chang, Strome, Pereira.
Acquisition, analysis, or interpretation of data: Ambro, Papadimitriou.
Drafting of the manuscript: Chang.
Critical revision of the manuscript for important intellectual content: Ambro, Strome, Papadimitriou, Pereira.
Administrative, technical, or material support: Ambro.
Study supervision: Papadimitriou, Pereira.
Conflict of Interest Disclosures: Dr Strome is a cofounder and stockholder in Gliknik Inc. He also receives royalties from the Mayo Clinic College of Medicine for intellectual property related to cell surface marker B7-H1. No other disclosures are reported.